Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | 563,325 | reported | 10 Nov 2023 | tx 22+796,825 |
| Structure Therapeutics Inc. | 51,804 | reported | 23 Jun 2025 | tx 2+89,304 |
| SEATTLE GENETICS INC /WA | 24,700 | reported | 04 Dec 2017 | tx 505+2,575,468−2,376,643 |
| STEMLINE THERAPEUTICS INC | 24,000 | reported | 19 Jun 2017 | tx 7+142,000 |
| Jade Biosciences, Inc. | 23,017 | reported | 29 Apr 2025 | tx 1+23,017 |
| Versartis, Inc. | 18,160 | reported | 20 Dec 2017 | tx 5+31,860 |
| Janux Therapeutics, Inc. | 11,667 | reported | 11 Jun 2025 | tx 8+53,309 |
| Adaptive Biotechnologies Corp | 3,759 | reported | 14 Feb 2021 | tx 40+99,151−170,000 |
| ADURO BIOTECH, INC. | 0 | reported | 11 Aug 2023 | tx 66+2,607,615−2,616,515 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jun 2025 | GRANT_AWARD | Structure Therapeutics Inc. | 51,804 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 3,750 | 0.00 USD | |
| 11 Jun 2025 | GRANT_AWARD | Janux Therapeutics, Inc. | 11,667 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Jade Biosciences, Inc. | 23,017 | 0.00 USD | deriv |
| 19 Jul 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 5,000 | 0.00 USD | |
| 19 Jul 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 2,500 | 0.00 USD | |
| 19 Jul 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 16,700 | 0.00 USD | deriv |
| 19 Jul 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 8,350 | 0.00 USD | deriv |
| 25 Jun 2024 | GRANT_AWARD | Structure Therapeutics Inc. | 37,500 | 0.00 USD | deriv |
| 10 Nov 2023 | PURCHASE | Atara Biotherapeutics, Inc. | 446,825 | 0.23 USD | first after silence |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 301,138 | — | |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 64,050 | — | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 50,001 | — | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 20,248 | — | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 30,797 | — | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 255,150 | 14.73 USD | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 11,300 | — | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 178,600 | 24.86 USD | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 271,647 | 25.23 USD | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 313,555 | 39.58 USD | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 353,358 | 39.65 USD | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 300,000 | 27.10 USD | deriv |
| 31 May 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 57,000 | 0.00 USD | |
| 31 May 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 79,500 | 0.00 USD | deriv |
| 24 Apr 2023 | SALE | ADURO BIOTECH, INC. | 1,200 | 22.26 USD |
3 purchases reported after at least 12 months of silence — most recent on 10 Nov 2023.